IDH1 and IDH2 isoforms are frequently mutated in various cancers, including glioma, acute myeloid leukemia, thyroid carcinomas, cartilaginous tumors, and intrahepatic cholangiocarcinoma (ICC) [66, 67, 68, 69]. This evidence concerns the gene IDH2 and cancer.